• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Catholic Review

Catholic Review

Inspiring the Archdiocese of Baltimore

Menu
  • Home
  • News
        • Local News
        • World News
        • Vatican News
        • Obituaries
        • Featured Video
        • En Español
        • Sports News
        • Official Clergy Assignments
        • Schools News
  • Commentary
        • Contributors
          • Question Corner
          • George Weigel
          • Elizabeth Scalia
          • Michael R. Heinlein
          • Effie Caldarola
          • Guest Commentary
        • CR Columnists
          • Archbishop William E. Lori
          • Rita Buettner
          • Christopher Gunty
          • George Matysek Jr.
          • Mark Viviano
          • Father Joseph Breighner
          • Father Collin Poston
          • Robyn Barberry
          • Hanael Bianchi
          • Amen Columns
  • Entertainment
        • Events
        • Movie & Television Reviews
        • Arts & Culture
        • Books
        • Recipes
  • About Us
        • Contact Us
        • Our History
        • Meet Our Staff
        • Photos to own
        • Books/CDs/Prayer Cards
        • CR Media platforms
        • Electronic Edition
  • Advertising
  • Shop
        • Purchase Photos
        • Books/CDs/Prayer Cards
        • Magazine Subscriptions
        • Archdiocesan Directory
  • CR Radio
        • CR Radio
        • Protagonistas de Fe
  • News Tips
  • Subscribe
A woman holds a birth control pill in this photo illustration. The Food and Drug Administration announced July 13, 2023, it approved the sale of a birth control pill without a prescription for the first time in the United States -- a move that will increase the availability of oral contraception and impact ongoing debates about abortion policy post-Dobbs. (OSV News photo photo/Eric Gaillard, Reuters)

FDA approves first over-the-counter birth control pill

July 14, 2023
By Kate Scanlon
OSV News
Filed Under: Feature, News, Respect Life, World News

Share
Share on Facebook
Share
Share this
Pin
Pin this
Share
Share on LinkedIn

WASHINGTON (OSV News) — The Food and Drug Administration announced July 13 it approved the sale of a birth control pill without a prescription for the first time in the United States, a move that will increase the availability of oral contraception and impact ongoing debates about abortion policy post-Dobbs.

In a statement, Dr. Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said the approval of Opill, a progestin-only pill, “marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States.”

“When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy,” Cavazzoni said.

Currently, a woman seeking to use birth control pills must do so with a doctor’s prescription.

While some have called for expanded access to contraception in the wake of the U.S. Supreme Court’s June 2022 decision in Dobbs v. Jackson Women’s Health Organization, which overturned the high court’s jurisprudence on abortion as a constitutional right, others have argued that proliferating contraception without medical supervision could lead to more unintended pregnancies.

In a guide about the church’s teaching on issues including contraception, the National Catholic Bioethics Center describes contraception as “any action that is specifically intended, whether as an end or as a means, to prevent procreation either before, at the moment of, or after sexual intercourse.”

While contraception “is never to be directly intended,” the guide states, its use for “therapeutic means needed to cure diseases is not illicit, even if it results in a foreseeable impediment to procreation — provided the impediment is not directly intended for any motive whatsoever.”

The Catechism of the Catholic Church teaches that unlike contraception, “the methods of birth regulation based on self-observation and the use of infertile periods, is in conformity with the objective criteria of morality.” These are known as fertility-based awareness methods of family planning; the methods are sometimes collectively referred to as natural family planning.

Opill is expected to be available for retail sale in the U.S. in the first quarter of 2024, its maker, Perrigo, said in a statement.

The FDA said the most common side effects of Opill include irregular bleeding, headaches, dizziness, nausea, increased appetite, abdominal pain, cramps and bloating; and the drug should not be used by those who have or have ever had breast cancer.

Bishop Robert E. Barron of Winona-Rochester, Minnesota, chairman of the U.S. Conference of Catholic Bishops’ Committee on Laity, Marriage, Family Life and Youth, said in a statement that the oral contraceptive announcement “flies in the face of responsible medical practice and concerns for women’s health.”

“Claims that the benefits of this action outweigh the risks are unfounded, especially in light of strong evidence of the many harmful risks of hormonal contraception to women’s health,” the bishop said. “Allowing this hormonal contraception to be dispensed ‘over the counter’ — without the supervision of a doctor and contrary to the mounting evidence of many harmful side effects — violates the Hippocratic Oath by putting the health of women at grave risk.”


Also see

Planned Parenthood

Judge blocks, for now, Planned Parenthood defunding provision backed by bishops

Report: US abortions continue post-Dobbs rise in part due to telehealth

In retrial, judge acquits man charged in assault on pro-life protester

Supreme Court rules states can deny Medicaid funds to Planned Parenthood

British Parliament ‘effectively decriminalizes’ abortion up to birth

Supreme Court takes up appeal from N.J. faith-based pregnancy centers

Copyright © 2023 OSV News

Print Print

Share
Share on Facebook
Share
Share this
Pin
Pin this
Share
Share on LinkedIn

Primary Sidebar

Kate Scanlon

Click here to view all posts from this author

For the latest news delivered twice a week via email or text message, sign up to receive our free enewsletter.

| MOST POPULAR |

  • 3 North Americans named to Vatican dicasteries for ecumenism, interreligious dialogue

  • Archbishop Lori announces clergy appointments, including pastor and associate pastors

  • St. Mary’s purchases former Annapolis Area Christian School

  • DUAL ENROLLMENT Double the learning: Dual enrollment provides college credit to high school students

  • Augustinian prior opens up about papal vacation, first encyclical, appointments and tennis

| Latest Local News |

Archbishop Lori announces clergy appointments, including pastor and associate pastors

DUAL ENROLLMENT

Double the learning: Dual enrollment provides college credit to high school students

St. Mary’s purchases former Annapolis Area Christian School

Radio Interview: Exploring the Nicene Creed – Part Two

St. Clement Mary Hofbauer adapts to times, cultures as it celebrates 100th anniversary

| Latest World News |

Judge blocks Trump birthright citizenship order as part of class action lawsuit

Ukraine religious leaders issue ‘desperate cry’ to world to end Russia’s war

care of creation

Pope Leo wears Chicago-made vestments to July 9 ‘care of creation’ Mass

sorry baby

Movie Review: Sorry, Baby

ICE

ICE deports Iowa parishioner to Guatemala homeland as supporters pray for his release

| Catholic Review Radio |

CatholicReview · Catholic Review Radio

Footer

Our Vision

Real Life. Real Faith. 

Catholic Review Media communicates the Gospel and its impact on people’s lives in the Archdiocese of Baltimore and beyond.

Our Mission

Catholic Review Media provides intergenerational communications that inform, teach, inspire and engage Catholics and all of good will in the mission of Christ through diverse forms of media.

Contact

Catholic Review
320 Cathedral Street
Baltimore, MD 21201
443-524-3150
mail@CatholicReview.org

 

Social Media

  • Facebook
  • Instagram
  • Twitter
  • YouTube

Recent

  • Expert discusses serious harms of smartphones for children and how to limit their use
  • Movie Review: Superman
  • Judge blocks Trump birthright citizenship order as part of class action lawsuit
  • Ukraine religious leaders issue ‘desperate cry’ to world to end Russia’s war
  • Pope Leo wears Chicago-made vestments to July 9 ‘care of creation’ Mass
  • Movie Review: Sorry, Baby
  • ICE deports Iowa parishioner to Guatemala homeland as supporters pray for his release
  • Come away and rest awhile
  • French woman hopes sharing mystical encounter with Minnesota Benedictine helps sainthood cause

Search

Membership

Catholic Media Assocation

Maryland-Delaware-DC Press Association

The Associated Church Press

© 2025 CATHOLIC REVIEW MEDIA, ALL RIGHTS RESERVED

en Englishes Spanish
en en